Results 81 to 90 of about 262,765 (147)

Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells. [PDF]

PLoS One
Calescibetta A, Dalton R, Fortenbery N, Ward G, Christiansen S, Chen X, Cheng P, Razabdouski T, Glode AJ, Tu N, Trinh TL, Liu J, Wright KL, Wei S, Eksioglu EA.   +14 more
europepmc   +1 more source

NK Cells in Health and Disease. [PDF]

Biomedicines
Blunt MD.
europepmc   +1 more source

Supercharged NK cells: a unique population of NK cells capable of differentiating stem cells and lysis of MHC class I high differentiated tumors. [PDF]

Cell Death Dis
Kaur K, Chen PC, Jewett A.
europepmc   +1 more source

Preclinical assessment of MAGE-A4-specific TCR-NK cells against solid tumors. [PDF]

Immunother Adv
Boieri M, Kmiecik J, Sandve M, Hannoun Z, Haugstøyl ME, Cardoso I, Vollmers S, Oldenburg AR, Mora-Velandia LM, Sletten C, Malachin G, Cieslar-Pobuda A, Christ L, Wanichawan P, Clement D, Saetersmoen ML, Haugen FL, Ruud AM, Ino JM, Oberoi P, Holm A, Gauthy E, Hassan NJ, Pollmann S, Weigand LU.   +24 more
europepmc   +1 more source

Association of NK cells with a shift in tryptophan catabolism in patients with heart failure after a single exercise exertion. [PDF]

Front Immunol
Swaminathan K, Astan B, Kaczmarek S, Lehnert K, Hannemann A, Koc A, Friedrich N, Budde K, Henning AK, Domańska G, Landmesser U, Templin C, Dörr M, Bahls M, Kränkel N.   +14 more
europepmc   +1 more source

ZNF683⁺ NK cells govern chemotherapy sensitivity in advanced HPSCC via reshaping immune microenvironment. [PDF]

Nat Commun
Li G, Xiao W, Wu H, Liu C, Gong L, Zhang H, Shao Z, Bai J, Xia X, Yi X, Wang Y, Lu S, She L, Wang J, Zhu G, Zhou X, Wang W, Shen L, Zhang N, Wang X, Huang D, Hou J, Qiu Y, Zhang X, Hung MC, Liu Y.   +25 more
europepmc   +1 more source

Beyond CRISPR: next-gen precision engineering of CAR-NK cells for enhanced persistence, trafficking, and tumor eradication. [PDF]

Cancer Cell Int
Dong A, Soleimani Samarkhazan H, Tavakoli F.   +2 more
europepmc   +1 more source

Recent advances in tumor immunotherapy based on NK cells. [PDF]

Front Immunol
Chen M, Zhang B, Mu X, Zhang B, Yang T, Zhang G, Gu Y, Pei B, Liang S.   +8 more
europepmc   +1 more source

Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts. [PDF]

Aging Cell
Koroma AK, Singh K, Wang Y, Krug L, Haas P, Wlaschek M, Sakk V, Schuster T, Fürst D, Schrezenmeier H, Dheenadayalan RP, Stilgenbauer S, Walter L, Geiger H, Scharffetter-Kochanek K, Maity P.   +15 more
europepmc   +1 more source

LAG3 Marks Activated but Hyporesponsive NK Cells. [PDF]

Eur J Immunol
Vasilyeva V, Makinson O, Chan C, Park M, O'Dwyer C, Ali A, Khan AUH, de Souza CT, Hasim MS, Asif S, Kurdieh R, Abou-Hamad J, Yakubovich E, Hodgins J, Haddad PA, Pietropaolo G, Mazej J, Seo H, Huang Q, Nersesian S, Chay D, Jacquelot N, Cook D, Lee SH, Sciumè G, Waggoner S, Ardolino M, Marotel M.   +27 more
europepmc   +1 more source